CHIKUNGUNYA IGM ANTIBODY

The CHIKUNGUNYA IGM ANTIBODY test detects IgM-class antibodies produced in response to Chikungunya virus (CHIKV), helping identify recent or acute infection. This serological assay is performed on a blood sample (serum or plasma) and is useful because IgM antibodies typically appear within days after symptom onset and indicate recent exposure. Performed at home by certified phlebotomists across Dubai and the UAE, the test supports timely clinical decisions and appropriate symptomatic management.

• Chikungunya IgM (CHIKV IgM)
• Antibody index / titre (when quantitative testing available)
• Sample type: Serum / Plasma
• Test method: ELISA / Immunoassay (as applicable)

• Within ~4–7 days after onset of fever and joint pain
• Acute febrile illness with severe arthralgia and rash
• Following travel to chikungunya-endemic areas or known mosquito exposure
• When distinguishing chikungunya from dengue or Zika in suspected cases
• Persistent or worsening joint symptoms after recent febrile illness

• Early identification of recent chikungunya infection to guide care
• Convenient at-home blood collection by certified phlebotomists across Dubai and the UAE
• Reduces need for clinic visits and potential exposure in healthcare settings
• Accurate serological testing using validated laboratory methods
• Results that assist physicians in treatment planning and differential diagnosis

• At-home venous blood sample collection (serum/plasma)
• Ideally performed from day 4–7 after symptom onset for IgM detection
• No fasting required; stay hydrated before sample collection
• Inform the phlebotomist/physician about recent vaccinations, infections, or immunosuppressive therapy